GCC Veterinary Glucose Monitoring Devices Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

GCC Veterinary Glucose Monitoring Devices

Market Overview

The GCC Veterinary Glucose Monitoring Devices Market is valued at USD 2.3 billion, based on a five-year historical analysis. This growth is primarily driven by the rising prevalence of diabetes in pets, increasing pet ownership, and heightened awareness of pet health wellness, particularly in the GCC where obesity-related conditions in animals are more common. Technological advancements, such as smart wearables, continuous monitoring systems, and AI-driven diagnostics, further bolster demand, reflecting expanding veterinary care expectations. Dominance in the region is shaped by Saudi Arabia and the UAE, where strong infrastructure, high disposable incomes, and urbanization encourage investment in advanced pet healthcare and diabetes management. The increasing number of veterinary clinics and pet care facilities in these countries also contributes to the market's growth, as pet owners seek better healthcare solutions for their animals. A notable regulatory development is the Saudi “Medical Devices Interim Regulation” from the SFDA, mandating pre-market approval and compliance with safety and quality standards for glucose monitoring devices, enhancing patient safety and elevating market reliability.

GCC Veterinary Glucose Monitoring Devices

Market Segmentation

By Device Type: The market is segmented into various device types, including handheld glucose meters, continuous glucose monitors, glucose test strips, and others. Handheld glucose meters are currently the leading sub-segment due to their ease of use and affordability, making them popular among pet owners and veterinary clinics. Continuous glucose monitors are gaining traction as they provide real-time data, which is crucial for managing diabetes in pets effectively. The demand for glucose test strips remains steady, as they are essential for the operation of handheld meters. By Animal Type: The segmentation by animal type includes dogs, cats, horses, and others. Dogs represent the largest segment due to their popularity as pets and the higher incidence of diabetes among them. Cats follow closely, as they also face similar health issues. Horses, while a smaller segment, are significant in the context of veterinary care, especially in regions where equestrian activities are prevalent. The growing awareness of diabetes management in pets is driving demand across all animal types.

GCC Veterinary Glucose Monitoring Devices Market

Competitive Landscape

The GCC Veterinary Glucose Monitoring Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis, IDEXX Laboratories, Allison Medical, Trividia Health, and Abbott Laboratories contribute to innovation, geographic expansion, and service delivery in this space.

Zoetis

1952 Parsippany-Troy Hills, New Jersey, USA

IDEXX Laboratories

1983 Westbrook, Maine, USA

Allison Medical

2000 San Diego, California, USA

Trividia Health

2004 Fort Lauderdale, Florida, USA

Abbott Laboratories

1888 Abbott Park, Illinois, USA

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Innovation Rate

GCC Veterinary Glucose Monitoring Devices Market Industry Analysis

Growth Drivers

Increasing Prevalence of Diabetes in Pets: The GCC region has witnessed a significant rise in diabetes cases among pets, with estimates indicating that approximately 1 in 300 dogs and 1 in 200 cats are diagnosed with diabetes. This translates to around 100,000 diabetic pets in the region, driving the demand for effective glucose monitoring devices. The growing pet population, projected to reach 32 million in future, further amplifies the need for reliable monitoring solutions to manage this chronic condition effectively. Rising Awareness About Pet Health: Pet owners in the GCC are increasingly prioritizing their pets' health, with veterinary spending expected to exceed $2 billion in future. This trend is fueled by educational campaigns and the proliferation of pet health information online, leading to a greater demand for advanced veterinary care, including glucose monitoring devices. As pet owners become more informed, they are more likely to invest in technologies that enhance their pets' quality of life and health management. Technological Advancements in Glucose Monitoring: The GCC market is benefiting from rapid technological innovations in glucose monitoring devices, including non-invasive and continuous glucose monitoring systems. In future, the introduction of smart devices integrated with mobile applications is expected to enhance user experience and data accuracy. These advancements are projected to improve the management of diabetes in pets, making it easier for pet owners and veterinarians to monitor glucose levels effectively and respond promptly to health changes.

Market Challenges

High Cost of Advanced Monitoring Devices: The adoption of advanced glucose monitoring devices in the GCC is hindered by their high costs, which can range from $600 to $2,500 per unit. This financial barrier limits accessibility for many pet owners, particularly in lower-income segments. As a result, the market faces challenges in achieving widespread adoption, despite the growing need for effective diabetes management solutions among pets. Limited Availability of Trained Veterinary Professionals: The GCC region is experiencing a shortage of trained veterinary professionals, with only about 6,000 licensed veterinarians available for a pet population of over 32 million. This shortage impacts the effective implementation of glucose monitoring technologies, as many clinics lack the expertise to utilize these devices properly. Consequently, the market's growth is constrained by the need for skilled professionals to support advanced veterinary care.

GCC Veterinary Glucose Monitoring Devices Market

Future Outlook

The future of the GCC veterinary glucose monitoring devices market appears promising, driven by increasing pet ownership and a growing focus on preventive healthcare. The integration of telemedicine and IoT technologies is expected to enhance monitoring capabilities, allowing for real-time data analysis and improved pet health management. As the market evolves, collaboration with pet insurance companies will likely facilitate broader access to these devices, making them more affordable and accessible for pet owners across the region.

Market Opportunities

Expansion of Veterinary Clinics and Hospitals: The GCC is witnessing a surge in the establishment of veterinary clinics and hospitals, with over 250 new facilities projected to open in future. This expansion will create a greater demand for glucose monitoring devices, as more veterinary practices seek to offer comprehensive diabetes management services to their clients, enhancing overall pet care. Increasing Demand for Home Monitoring Solutions: As pet owners seek convenience, the demand for home glucose monitoring solutions is on the rise. With an estimated 45% of pet owners expressing interest in home monitoring devices, manufacturers have a significant opportunity to develop user-friendly products that cater to this growing market segment, ultimately improving pet health outcomes.

Please Note: The report will take approximately 4–6 weeks to prepare and deliver.

Update cycle typically involves:

Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions. Show more